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1. INTRODUCTION {#cas14406-sec-0001}
===============

In Japan, the rate of age‐adjusted incidence of cervical cancer had been decreasing significantly in the 1980s and 1990s. However, the rate started to increase clearly after 2000.[^1^](#cas14406-bib-0001){ref-type="ref"} Many cervical cancers are known to be caused by persistent infection with human papillomavirus (HPV), including HPV 16 and 18. Although cervical cancers caused by HPV 16 and 18 infection are vaccine‐preventable, the inoculation rate varies depending on the country.[^2^](#cas14406-bib-0002){ref-type="ref"}

In Japan, the emergency promotion project of HPV started in 2010. It targeted students in 7th to 10th grade (6th grade students were included in some local government areas.) The national HPV vaccination program started in April 2013, which targeted 7th grade (including 6th grade to 10th grade) students standardly. However, the serious adverse events after HPV vaccination were widely reported in the media. The Ministry of Health, Labour and Welfare of Japan (MHLW) announced the suspension of the governmental recommendation for HPV vaccination in 2013, and the inoculation rate has since sharply declined.[^3^](#cas14406-bib-0003){ref-type="ref"}, [^4^](#cas14406-bib-0004){ref-type="ref"}, [^5^](#cas14406-bib-0005){ref-type="ref"}, [^6^](#cas14406-bib-0006){ref-type="ref"} It is very important to recommend cervical cancer screening to the unvaccinated generation, and to resume the active recommendation of HPV vaccination.[^7^](#cas14406-bib-0007){ref-type="ref"}

To determine the inoculation rate of the HPV vaccine, each local government investigated the number of inoculations and the MHLW announced the estimated inoculation rate. However, the estimated inoculation rate and the actual numbers surveyed by the local governments were very different. For example, the inoculation rate of girls born in fiscal year (FY) 2000 was estimated to be 42.9% by the Council of the MHLW,[^8^](#cas14406-bib-0008){ref-type="ref"} which was significantly higher than the inoculation rate of those in Sakai city in our previous report.[^3^](#cas14406-bib-0003){ref-type="ref"} The aim of this study is to estimate the HPV vaccination rate of each birth FY more accurately for the prevention of cervical cancer. Girls born in or after FY2000, who have been supposed to have a lower vaccination rate, would now be expected to be sexually active. We need to understand the risk of developing cervical cancer of those females.

2. MATERIALS AND METHODS {#cas14406-sec-0002}
========================

The number of vaccinated girls, according to the Council of the MHLW,[^8^](#cas14406-bib-0008){ref-type="ref"} is shown in Table [1](#cas14406-tbl-0001){ref-type="table"}. Their method of calculation is as follows. The HPV vaccination program in Japan involves three inoculations. The number of girls who had been vaccinated at least once are shown in Table [1](#cas14406-tbl-0001){ref-type="table"} and "Age" represents the age at first inoculation.

###### 

Numbers of Japanese girls inoculated with human papillomavirus vaccine, according to the Council of the Ministry of Health, Labour and Welfare, Japan

  Birth FY   FY 2010   FY 2011   FY 2012   FY 2013   FY 2014   FY 2015   Number of female individuals   Vaccinated rate                                              
  ---------- --------- --------- --------- --------- --------- --------- ------------------------------ ----------------- ---- ------ ---- ----- --------- --------- ------
  1993       17        0         18        --        19        --        20                             --                21   --     22   --    0         566 800   0.0
  1994       16        178 852   17        71 307    18        --        19                             --                20   --     21   --    250 159   592 400   42.2
  1995       15        64 387    16        252 362   17        2928      18                             --                19   --     20   --    319 677   589 300   54.2
  1996       14        70 362    15        356 690   16        22 539    17                             --                18   --     19   --    449 590   554 500   81.1
  1997       13        60 149    14        348 607   15        45 916    16                             2861              17   --     18   --    457 532   563 400   81.2
  1998       12        4364      13        363 190   14        61 855    15                             4780              16   136    17   --    434 325   576 700   75.3
  1999       11        0         12        193 635   13        222 814   14                             8518              15   443    16   67    425 476   573 800   74.2
  2000       10        --        11        3418      12        190 636   13                             50 552            14   979    15   220   245 805   572 400   42.9
  2001       9         --        10        --        11        3373      12                             29 440            13   1324   14   482   34 619    563 800   6.1
  2002       8         --        9         --        10        --        11                             2505              12   879    13   642   4026      551 700   0.7
  2003       7         --        8         --        9         --        10                             --                11   118    12   422   540       539 100   0.1
  2004       6         --        7         --        8         --        9                              --                10   --     11   55    55        539 100   0.0

Cumulative vaccination rates for girls born in fiscal year (FY) 1999 and FY2000 were reported to be 74.2% and 42.9%, respectively.

--, not vaccinated.
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They based their calculations on the implementation report of the emergency promotion project of HPV vaccination from FY2010 to FY2012. In FY2010, the age at the end of the FY was used. For example, all 6th grade girls were regarded as 12 years old (Figure [1A](#cas14406-fig-0001){ref-type="fig"}). In FY2011 and FY2012, the inoculation number in each grade was evenly divided into ages. For example, 6th grade girls were evenly divided into 11 years old and 12 years old (Figure [1](#cas14406-fig-0001){ref-type="fig"}B). In FY2013 and FY2014, the recording method was changed, and inoculation numbers were calculated from the data of the regional health promotion program report. The real age was used in the data, not the age of FY. For example, the girls vaccinated at 12 years old were recorded in the 12 y/o cell (Figure [1](#cas14406-fig-0001){ref-type="fig"}C). For FY2015, the MHLW obtained an estimate from the inoculation rate in FY2014 and halved the result. Data were published as estimated inoculation numbers on 1st October 2017. However, this estimation included data based on 2 different standards: one based on FY and the other on actual age.

![Method used by the Ministry of Health, Labour and Welfare of Japan (MHLW) to calculate the human papillomavirus vaccine uptake rates for the target girls according to birth fiscal year (FY). Age (y) in 2010 (A), 2011 (B), and 2013 (C). y/o, years old](CAS-111-2156-g001){#cas14406-fig-0001}

In our calculation model, the standard was unified to FY in which girls were born. The numbers of inoculation in our model are based on the number of vaccinated girls announced by the Council of the MHLW[^8^](#cas14406-bib-0008){ref-type="ref"} and the "Report on Regional Public Health Services and Health Promotion Services" published by MHLW.[^9^](#cas14406-bib-0009){ref-type="ref"}, [^10^](#cas14406-bib-0010){ref-type="ref"}, [^11^](#cas14406-bib-0011){ref-type="ref"}, [^12^](#cas14406-bib-0012){ref-type="ref"}, [^13^](#cas14406-bib-0013){ref-type="ref"}The female reference population was calculated from the national population census.[^14^](#cas14406-bib-0014){ref-type="ref"}

3. RESULTS {#cas14406-sec-0003}
==========

The data of FY2010 shown by the Council of MHLW were acceptable. In the MHLW data, 6th grade girls in FY2011 were evenly divided into 11 and 12 years old. As 5th grade girls were not targeted for HPV vaccination, it is estimated that the inoculation number of 6th grade girls in FY2011 was approximately 6836, which is double 3418 allocated to 11 years old. The number of 7th grade girls vaccinated in FY2011 became 380 434, which is double 190 217, calculated by subtracting 3418 from 193 635 distributed to 12 years old. The inoculation number of 8th grade girls became 345 946, which is double 172 973, calculated by subtracting 190 217 from 363 190 distributed to 13 years old (Figure [2](#cas14406-fig-0002){ref-type="fig"}). All cells could be calculated in the same way as in FY2011 and FY2012.

![Method for correcting original data used by the Ministry of Health, Labour and Welfare of Japan (MHLW) to calculate human papillomavirus (HPV) vaccine uptake rates. FY, fiscal year](CAS-111-2156-g002){#cas14406-fig-0002}

In FY2013, HPV vaccine became a routine immunization and the target was set to be from 6th to 10th grade with the standard target of 7th grade (13 years old). It is more accurate to estimate the inoculation number of 7th grade girls after fixing the numbers of 6th grade and 10th grade, while the numbers of 5th and 11th grade were considered to be almost zero. The inoculation number of 6th grade girls in FY2013 was 5010, which is double 2505, and that of 10th grade was 5722, which is double 2861 allocated to 16 years old. The number in 9th grade was 3838, which is double 1919, calculated by subtracting 2861 from 4780 who were inoculated at 15 years old. The inoculation number in 8th grade was 13 198, which is double 6599, calculated by subtracting 1919 from 8518 who were inoculated at 14 years old (Figure [2](#cas14406-fig-0002){ref-type="fig"}). The same calculation was done for FY2014, FY2015, and FY2016 and corrected data are shown in Table [2](#cas14406-tbl-0002){ref-type="table"}.

###### 

Corrected numbers of Japanese girls inoculated with human papillomavirus vaccine

  Birth FY   FY 2010   FY 2011   FY 2012   FY 2013   FY 2014   FY 2015   FY2016   FY2017   No. of female persons   Vaccination rate                                                          
  ---------- --------- --------- --------- --------- --------- --------- -------- -------- ----------------------- ------------------ ---- ------ ---- ----- ---- ------ --------- --------- ------
  1993       17        --        18        --        19        --        20       --       21                      --                 22   --     23   --    24   --     --        --        0.0
  1994       16        178 852   17        142 613   18        --        19       --       20                      --                 21   --     22   --    23   --     321 465   579 098   55.5
  1995       15        64 387    16        362 112   17        5855      18       --       19                      --                 20   --     21   --    22   --     432 354   588 260   73.5
  1996       14        70 362    15        351 268   16        39 224    17       --       18                      --                 19   --     20   --    21   --     460 854   589 312   78.2
  1997       13        60 149    14        345 946   15        52 608    16       5722     17                      --                 18   --     19   --    20   --     464 425   589 055   78.8
  1998       12        4364      13        380 434   14        71 102    15       3838     16                      272                17   --     18   --    19   --     460 010   584 594   78.7
  1999       11        --        12        6836      13        374 526   14       13 198   15                      614                16   256    17   --    18   --     395 430   573 656   68.9
  2000       10        --        11        --        12        6746      13       70 888   14                      1344               15   1112   16   560   17   --     80 650    565 541   14.3
  2001       9         --        10        --        11        --        12       5010     13                      1413               14   294    15   534   16   1366   8617      553 103   1.6
  2002       8         --        9         --        10        --        11       --       12                      236                13   857    14   154   15   800    2047      543 086   0.4
  2003       7         --        8         --        9         --        10       --       11                      --                 12   178    13   490   14   384    1052      529 073   0.2
  2004       6         --        7         --        8         --        9        --       10                      --                 11   --     12   96    13   663    759       511 899   0.1
  2005       5         --        6         --        7         --        8        --       9                       --                 10   --     11   --    12   134    134       522 030   0.0
  2006       4         --        5         --        6         --        7        --       8                       --                 9    --     10   --    11   --     --        --        0.0

Cumulative vaccination rates for girls born in fiscal year (FY) 1999 and FY2000 were 68.9% and 14.3%, respectively, after the calculation.

--, not vaccinated.

John Wiley & Sons, Ltd

The cumulative vaccination rates for girls born in FY1999 and FY2000 were reported to be 74.2% and 42.9%, respectively, but they were revised to 68.9% and 14.3%, respectively, after the calculation (Figure [3](#cas14406-fig-0003){ref-type="fig"}).

![Year‐on‐year comparisons of the rates of human papillomavirus vaccination in Japan, estimated by the Ministry of Health, Labour and Welfare of Japan (MHLW) (filled columns) and our corrected rates (dotted fill). The corrected vaccination rate for female individuals born in fiscal year (FY) 2000 was found to be significantly lower than that estimated by the MHLW. Vaccination rates among generations born after FY2000 are considered to be quite low](CAS-111-2156-g003){#cas14406-fig-0003}

4. DISCUSSION {#cas14406-sec-0004}
=============

In this study, HPV vaccination rates were recalculated based on data from the Council of the MHLW. Until now, the cumulative vaccination rate of girls born in FY2000 was regarded to be as high as 42.9%. When the suspension of the governmental recommendation was announced in FY2013, the girls born in FY2000 turned 13 years old, the starting age of the target of HPV vaccination. The vaccination rate of this generation is considered to be quite low. This study has revealed that the real vaccination rate is only 14.3%.

The most significant reason of this discrepancy is that there was a mix of FY‐based annual statistics and yearly surveys. Moreover, as the survey timing varied in each local government, it was difficult to determine the exact numbers of HPV vaccine recipients. In the estimates made by the Council of the MHLW, there is a problem in the statistical methods, such as dividing the inoculation number into 2 grades, one of which is not the target age for vaccination. By correcting this point, our estimate is closer to the real numbers in the local government surveys. Our estimate is considered to be useful for predicting the future incidence rate of cervical cancer.

Female individuals born in or after FY2000 have been confirmed to be exposed to the same cervical cancer risk as before the HPV vaccine was introduced in Japan. The vaccination rate for those born in FY2000 was found to be significantly lower than the MHLW data, so that their risk of future cervical cancer will return to the same level as the prevaccine generation. They will become the targets of cervical cancer screening at the age of 20 years after FY2020. Recommendation for cervical cancer screening should be strengthened for these women.
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